Pink Sheet is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA adoption of voluntary labeling program for PPA diet aids urged by NDMA.

This article was originally published in The Tan Sheet

Executive Summary

FDA ADOPTION OF NDMA VOLUNTARY LABELING PROGRAM FOR PPA DIET AIDS URGED by the Nonprescription Drug Manufacturers Association in May 14 comments to FDA. The comments respond to the agency's Feb. 14 proposal to require warning labels for all phenylpropanolamine-containing OTCs ("The Tan Sheet" Feb. 19, p. 9). Although the agency proposal is similar to the industry's voluntary program for appetite suppressants, NDMA said it has "substantial" concerns with the way the label information would be presented under the proposal.
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS085436

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel